Mutual Recognition of IRB Reviews for Collaborative Studies
1 April 2025
Find out how major Singapore research institutions have agreed to streamline ethics reviews for collaborative studies, so each study only needs a single IRB review from 1 April 2025.
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
01 April 2025: Mutual Recognition of IRB Reviews for Collaborative Studies Reviewed by A*STAR IRB, NHG DSRB, NTU-IRB, NUS-IRB and SingHealth CIRB
A*STAR Research Entities (ARES), National Healthcare Group (NHG), Nanyang Technological University (NTU), National University of Singapore (NUS) and SingHealth (SHS) have entered into a Mutual Recognition Agreement streamlining the ethics review procedures for Collaborative Studies to avoid duplicative review.
With effect from 1 April 2025, all new IRB applications involving A*STAR, NHG, NTU, NUHS, NUS and SingHealth sites, or their Partner Institutions, are eligible to benefit from the IRBs mutual recognition arrangement and have their studies reviewed by a single IRB.
For more information, please refer to the latest Mutual Recognition FAQ (opens in new tab).
If you have any questions, please contact us at nhggroup.OHRPP@nhghealth.com.sg (opens in new tab)
